TransCode Therapeutics, Inc.
RNAZ · NASDAQ
Bulios Fair Price
$2.14
21.6% upside
Trenutna cena
$1.76
Po podatkih Bulios Fair Price je delnica RNAZ trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
TransCode Therapeutics, Inc. is a biotechnology company that focuses on developing therapeutic products based on RNA. The company employs advanced technologies to modify and optimize RNA in order to create drugs for various diseases. Their research centers on utilizing RNA therapy to influence gene expression and provide novel approaches to treating various health conditions. TransCode Therapeutics aims to bring innovative treatment options and contribute to advancements in the field of biotechnology and therapeutic strategies. Investors interested in advancements in biotechnology and RNA therapy might see potential in TransCode Therapeutics, Inc. shares for innovation and growth in this field.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Philippe Calais
Employees
12
Headquarters
Boston
Prihajajoči dogodki
Earnings
Upcoming earnings report